TRDA FY 2025 Earnings — Entrada Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

TRDAEntrada Therapeutics, Inc.

$502M

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$25M-87.9% YoY

Gross Profit

$21M83.9% margin

Operating Income

-$156M-613.7% margin

Net Income

-$144M-565.5% margin

EPS (Diluted)

$-3.47

Cash Flow

Operating Cash Flow

-$129M

Free Cash Flow

-$130M

Stock-Based Comp.

$20M

Balance Sheet

Total Assets

$377M

Total Liabilities

$71M

Stockholders' Equity

$306M

Cash & Equivalents

$90M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$25M	$211M	-87.9%
Gross Profit	$21M	$211M	-89.9%
Operating Income	-$156M	$47M	-431.8%
Net Income	-$144M	$66M	-319.0%